Mitsui has a led the round that took the Qualcomm-backed clinical testing software company's overall funding to $38m.
US-based medical testing software developer GoBalto has raised $12m in a series C round led by Mitsui Global Investment, a corporate venturing fund owned by conglomerate Mitsui, Dow Jones reported yesterday.
Qualcomm Life, the healthcare subsidiary of wireless technology producer Qualcomm, also participated, as did Dolby Family Ventures, Aberdare Ventures, West Health Investment Fund and EDBI.
GoBalto produces software that can assist in clinical studies for pharmaceutical, biotechnology and medical device products.
The cash will be used to boost the…